United Therapeutics Corporation Financial Ratios — UTH Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	23.78	29.96	14.9	27.19	46.03	41.5	21.14	24.1	-3.75	16.67	12.94	16.61	18.27	19.23	19.71
Return on Assets (%)	14.77	19.36	9.4	17.12	32.03	31.65	16.06	18.76	-2.86	12.07	9.73	12.97	14.91	16.45	17.51
Return on Capital (%)	19.34	24.34	12.55	23.57	43.68	41.32	19.97	22.1	- -	13.64	10.96	14.53	16.78	18.3	19.51
Return on Invested Capital (%)	19.12	22.44	12.36	23.4	29.1	41.23	20.91	23.04	- -	12.22	9.95	14.48	14.91	15.93	16.8
Gross Margin (%)	88.04	86.98	88.26	90.23	95.29	95.45	93.87	87.79	91.88	92.71	92.73	92.17	88.94	89.24	87.92
EBITDA Margin (%)	45.52	48.99	28.99	44.32	49.93	68.38	49.03	51.68	-9.78	43.38	35.94	53.25	53.19	50.38	49.58
Operating Margin (%)	42.76	46.03	26.19	41.82	47.69	66.41	59.4	49.48	-12.95	40.02	32.98	50.6	50.91	50.33	47.67
Incremental Operating Margin (%)	97.46	60.07	- -	143.6	90.36	272.71	- -	225.13	554.75	2,264.35	- -	168.98	52.45	47.86	22.63
Pretax Margin (%)	40.25	48.1	24.97	40.76	71.25	66.31	44.6	46.62	-11.39	43.07	35.24	49.09	54.75	53.49	53.85
Profit Margin (%)	29.32	33.23	15.63	26.4	44.45	44.64	24.22	36.2	-7.21	34.71	28.23	37.56	42.31	41.53	41.94
Net Income to Common Margin (%)	29.32	33.23	15.63	26.4	44.45	44.64	24.22	36.2	-7.21	34.71	28.23	37.56	42.31	41.53	41.94
Effective Tax Rate (%)	27.37	30.91	37.41	35.24	37.61	32.68	45.69	22.36	- -	19.42	19.89	23.49	22.72	22.35	22.12
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	23.78	29.96	14.9	27.19	46.03	41.5	21.14	24.1	-3.75	16.67	12.94	16.61	18.27	19.23	19.71

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	266	276	286	126	5	- -	250	250	850	800	800	800	700	300	- -
ST Debt	- -	1	282	126	5	- -	- -	- -	250	- -	- -	- -	400	300	- -
LT Debt	266	275	4	- -	- -	- -	250	250	600	800	800	800	300	- -	- -
Total Debt/EBITDA	0.79	0.62	0.88	0.22	0.01	- -	0.3	0.3	-6	1.24	1.32	0.78	0.57	0.21	- -
Net Debt/EBITDA	0.3	0.27	0.01	-0.48	-1.13	-0.94	-0.54	-0.5	-0.79	0.1	-0.16	-0.16	-0.41	-0.96	-0.99
Total Debt/EBIT	0.84	0.66	0.98	0.23	0.01	- -	0.31	0.31	-4.53	1.35	1.44	0.82	0.59	0.22	- -
Net Debt/EBIT	0.32	0.29	0.01	-0.5	-1.18	-0.96	-0.56	-0.52	-0.59	0.1	-0.17	-0.16	-0.43	-1.01	-1.04
EBITDA to Interest Expense	15.83	26.97	17.93	32.44	155.72	280.33	93.99	60.53	-3.21	27.38	32.57	31.82	20.88	33.79	80.93
EBITDA-CapEx/Interest Expense	14.15	20.25	16.16	29.75	145.13	269.26	84.4	47.26	-5.1	24.86	26.08	27.54	16.99	28.04	53.95
EBIT to Interest Expense	14.87	25.34	16.2	30.61	148.72	272.23	113.88	57.94	-4.24	25.26	29.89	30.24	19.98	33.76	77.81
Interest Expense	21	17	18	18	5	4	9	14	44	24	19	32	59	43	20
Common Equity/Total Assets	62.48	66.64	60.32	65.93	72.72	79.61	72.99	81.99	71.05	73.57	76.59	79.36	83.5	87.51	90.05
Long-Term Debt/Equity (%)	27.69	25.12	0.29	- -	- -	- -	11.79	8.9	21.58	23.56	20.21	16.68	5.01	- -	- -
Long-Term Debt/Capital (%)	21.68	20.06	0.23	- -	- -	- -	10.54	8.18	16.53	19.07	16.81	14.29	4.49	- -	- -
Long-Term Debt/Total Assets (%)	17.5	16.91	0.18	- -	- -	- -	8.68	7.35	15.33	17.33	15.48	13.24	4.19	- -	- -
Total Debt/Equity (%)	27.69	25.24	21.94	9.99	0.34	- -	11.79	8.9	30.57	23.56	20.21	16.68	11.7	4.66	- -
Total Debt/Capital (%)	21.68	20.15	17.99	9.08	0.34	- -	10.54	8.18	23.41	19.07	16.81	14.29	10.47	4.45	- -
Total Debt/Total Assets (%)	17.5	16.99	13.71	6.71	0.25	- -	8.68	7.35	21.72	17.33	15.48	13.24	9.77	4.07	- -
Net Debt to Equity	10.73	11.17	0.15	-21.44	-51.66	-54.94	-21.46	-14.93	4.01	1.81	-2.39	-3.36	-8.48	-21.68	-21.94
Net Debt/Capital (%)	9.69	10.05	0.15	-27.28	-106.87	-121.9	-27.32	-17.55	3.86	1.77	-2.45	-3.48	-9.27	-27.68	-28.11
EBITDA	338	449	324	571	732	1,093	846	841	-142	644	606	1,031	1,238	1,450	1,578
EBITDA-CapEx	302	337	292	524	682	1,050	760	657	-225	584	485	892	1,008	1,203	1,052
Operating Income (Loss)	318	422	292	539	699	1,062	1,025	805	-188	594	556	980	1,185	1,448	1,517

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.9	2.71	1.01	1.38	2.16	3.16	2.09	5.12	3.21	5.68	6.32	8.27	3.72	4.43	5.21
Current Ratio	2.65	3.78	1.33	1.9	2.89	4.29	3.26	6.39	4.03	6.7	7.61	9.85	4.41	5.25	6.6
Quick Ratio	2.32	3.37	1.19	1.7	2.6	3.81	2.75	5.75	3.54	6.16	6.97	8.91	4.07	4.8	5.83
CFO/Avg Current Liab	0.78	1.66	0.98	0.6	0.81	1.66	1.22	2.16	-0.56	1.92	1.9	2.47	1.7	1.72	2.4
Common Equity/Total Assets	62.48	66.64	60.32	65.93	72.72	79.61	72.99	81.99	71.05	73.57	76.59	79.36	83.5	87.51	90.05
Long-Term Debt/Equity (%)	27.69	25.12	0.29	- -	- -	- -	11.79	8.9	21.58	23.56	20.21	16.68	5.01	- -	- -
Long-Term Debt/Capital (%)	21.68	20.06	0.23	- -	- -	- -	10.54	8.18	16.53	19.07	16.81	14.29	4.49	- -	- -
Long-Term Debt/Total Assets (%)	17.5	16.91	0.18	- -	- -	- -	8.68	7.35	15.33	17.33	15.48	13.24	4.19	- -	- -
Total Debt/Equity (%)	27.69	25.24	21.94	9.99	0.34	- -	11.79	8.9	30.57	23.56	20.21	16.68	11.7	4.66	- -
Total Debt/Capital (%)	21.68	20.15	17.99	9.08	0.34	- -	10.54	8.18	23.41	19.07	16.81	14.29	10.47	4.45	- -
Total Debt/Total Assets (%)	17.5	16.99	13.71	6.71	0.25	- -	8.68	7.35	21.72	17.33	15.48	13.24	9.77	4.07	- -
CFO/Total Liabilities	44.78	60.86	54.29	57.41	65.47	138.89	62.53	131.22	-18.23	61.95	49.43	64.31	82.73	144.25	199.18
CFO/CapEx	6.95	2.89	13.33	7.5	7.69	14.9	5.49	4.22	-2.47	12.74	4.95	5.78	4.24	5.38	2.97
Altman's Z-Score	- -	- -	- -	- -	- -	12.3	8.75	8.03	3.98	5.79	7.15	8.75	7.77	13.35	19.89

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	9.15	8.92	9.2	8.93	8.26	7.85	6.74	6.89	8.86	9.61	9.47	9.24	9.32	10.31	10.11
Days Sales Outstanding	39.88	40.9	39.69	40.87	44.21	46.49	54.12	53.01	41.2	37.99	38.56	39.5	39.15	35.4	36.1
Inventory Turnover	2.18	2.87	3.08	2.2	0.93	0.8	1.02	1.9	1.21	1.2	1.36	1.55	2.41	2.3	2.25
Days Inventory Outstanding	167.3	127.33	118.32	166.24	392.05	455.12	358.96	191.87	301.68	303.72	268.61	235.71	151.53	158.93	161.9
Accounts Payable Turnover	3.13	3.85	16.75	21.17	11.5	11.72	13.77	12.18	6.67	14.46	32.86	40.46	55.11	61.34	62.53
Accounts Payable Turnover Days	116.45	94.84	21.79	17.24	31.73	31.15	26.51	29.97	54.75	25.25	11.11	9.02	6.62	5.95	5.84
Cash Conversion Cycle	90.73	73.39	136.22	189.88	404.53	470.46	386.57	214.9	288.14	316.46	296.06	266.19	184.06	188.38	192.15
Inventory to Cash Days	-127.43	-86.43	-78.63	-125.37	-347.84	-408.63	-304.84	-138.86	-260.48	-265.72	-230.05	-196.21	-112.38	-123.52	-125.8
Inventories	46	37	48	67	81	100	108	101	93	87	94	102	112	158	183
Raw Materials	9	14	18	21	23	25	28	24	21	18	18	18	22	29	31
Work In Process	14	12	12	16	23	25	24	28	29	30	32	33	34	34	35
Finished Goods	23	12	18	30	36	50	56	49	43	39	44	51	56	95	117
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	6,190	6,472	4,612	3,908	6,735	9,709	12,692	10,295	15,915	21,955
- Cash & Cash Equivalents	163	154	284	398	832	1,023	705	669	738	739	895	961	1,208	1,697	1,557
+ Preferred Equity and Hybrid Capital	11	11	45	23	11	11	19	19	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	266	276	286	126	5	- -	250	250	850	800	800	800	700	300	- -
Enterprise Value	- -	- -	- -	- -	- -	5,150	5,814	3,466	3,272	5,700	8,579	10,654	8,000	12,948	19,035
Total Capital	1,225	1,371	1,590	1,392	1,605	1,862	2,371	3,058	3,630	4,195	4,759	5,597	6,685	6,744	7,096
Total Debt/Capital (%)	21.68	20.15	17.99	9.08	0.34	- -	10.54	8.18	23.41	19.07	16.81	14.29	10.47	4.45	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.04	0.07	0.26	0.14	0.09	0.08	0.09	0.02	- -
EV/Sales	- -	- -	- -	- -	- -	3.22	3.37	2.13	2.26	3.84	5.09	5.5	3.44	4.5	5.98
EV/EBITDA	- -	- -	- -	- -	- -	4.71	6.87	4.12	- -	8.86	14.16	10.33	6.46	8.93	12.06
EV/EBIT	- -	- -	- -	- -	- -	4.85	7.13	4.3	- -	9.6	15.43	10.87	6.75	9.4	12.75
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	7.97	12.14	4.39	- -	7.36	13.99	12.88	7.81	9.52	12.08
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	8.54	14.8	5.73	- -	7.97	17.43	15.47	10.08	11.62	18.12
Diluted Market Cap	- -	- -	- -	- -	- -	6,743	6,721	4,656	3,901	6,749	10,181	13,373	10,877	17,217	24,097
Diluted Enterprise Value	- -	- -	- -	- -	- -	5,703	6,063	3,509	3,265	5,714	9,051	11,334	8,582	14,250	21,176
EV per Share	- -	- -	- -	- -	- -	119.87	134.46	79.51	74.57	128.07	190.18	231.44	170.07	288.81	436.15
TTM Sales	743	916	1,117	1,289	1,466	1,599	1,725	1,628	1,449	1,483	1,686	1,936	2,328	2,877	3,183
TTM EBITDA	338	449	324	571	732	1,093	846	841	-142	644	606	1,031	1,238	1,450	1,578
TTM Operating Income	318	422	292	539	699	1,062	1,025	805	-188	594	556	980	1,185	1,448	1,517
TTM Cash Flow to Firm	266	335	437	367	386	646	479	789	- -	775	613	827	1,024	1,360	1,576
TTM Free Cash Flow to Firm	230	223	405	319	336	603	393	605	- -	715	492	688	793	1,114	1,050

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	11.23	17.33	7.84	-13.44	9.69	21.33	20.15	14.55	15.93	23.28
EV/EBIT	- -	- -	- -	- -	- -	4.85	7.13	4.3	- -	9.6	15.43	10.87	6.75	9.4	12.75
Enterprise Value	- -	- -	- -	- -	- -	5,150	5,814	3,466	3,272	5,700	8,579	10,654	8,000	12,948	19,035
Low Price	- -	- -	- -	- -	- -	98.42	114.47	101.2	74.95	79.37	148.28	158.28	203.58	208.9	266.02
EV/Sales	- -	- -	- -	- -	- -	3.22	3.37	2.13	2.26	3.84	5.09	5.5	3.44	4.5	5.98
EV/EBITDA	- -	- -	- -	- -	- -	4.71	6.87	4.12	- -	8.86	14.16	10.33	6.46	8.93	12.06
Price/Earnings	- -	- -	- -	- -	- -	8.84	15.76	7.81	- -	12.99	20.31	17.25	10.4	13.43	16.7
Price/Earnings Average	- -	- -	- -	- -	- -	7.35	14	8.81	- -	9.65	17.78	13.65	11.05	11.33	11.89
Price/Earnings High	- -	- -	- -	- -	- -	8.92	17.76	11.23	- -	13.05	20.42	17.9	13.32	15.85	17.25
Price/Earnings Low	- -	- -	- -	- -	- -	6.04	12.05	7.47	- -	6.81	13.99	9.9	9.67	7.9	8.83
Price/Book Value	- -	- -	- -	- -	- -	3.34	3.08	1.65	1.41	1.98	2.45	2.65	1.72	2.47	3.09
Price/Book Value Average	- -	- -	- -	- -	- -	2.78	2.74	1.87	1.49	1.47	2.15	2.09	1.83	2.08	2.2
Price/Book Value High	- -	- -	- -	- -	- -	3.37	3.47	2.38	2	1.99	2.47	2.75	2.2	2.91	3.2
Price/Book Value Low	- -	- -	- -	- -	- -	2.28	2.35	1.58	1.18	1.04	1.69	1.52	1.6	1.45	1.64
Price/Tangible Book Value	- -	- -	- -	- -	- -	3.41	3.15	1.76	1.49	2.08	2.48	2.67	1.75	2.51	3.15
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	2.83	2.8	1.99	1.58	1.55	2.17	2.11	1.86	2.12	2.24
Price/Tangible Book Value High	- -	- -	- -	- -	- -	3.44	3.55	2.53	2.12	2.09	2.49	2.77	2.25	2.97	3.25
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	2.33	2.41	1.69	1.25	1.09	1.71	1.53	1.63	1.48	1.66
Price/Sales	- -	- -	- -	- -	- -	3.95	3.82	2.83	2.69	4.51	5.73	6.48	4.4	5.58	7
Price/Sales Average	- -	- -	- -	- -	- -	3.28	3.39	3.19	2.86	3.35	5.02	5.13	4.68	4.71	4.98
Price/Sales High	- -	- -	- -	- -	- -	3.98	4.3	4.06	3.84	4.53	5.76	6.72	5.64	6.58	7.23
Price/Sales Low	- -	- -	- -	- -	- -	2.7	2.92	2.7	2.27	2.37	3.95	3.72	4.09	3.28	3.7
Price/Cash Flow	- -	- -	- -	- -	- -	9.81	13.89	5.91	-18.88	8.85	16.16	15.63	10.47	12.09	14.27
Price/Cash Flow Average	- -	- -	- -	- -	- -	8.15	12.34	6.67	-20.07	6.58	14.14	12.37	11.13	10.21	10.16
Price/Cash Flow High	- -	- -	- -	- -	- -	9.89	15.65	8.5	-26.92	8.89	16.24	16.22	13.42	14.27	14.75
Price/Cash Flow Low	- -	- -	- -	- -	- -	6.7	10.62	5.66	-15.89	4.64	11.13	8.97	9.74	7.12	7.55
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	9.33	15.39	8.84	-14.28	7.2	18.66	15.95	15.46	13.45	16.57
Price/Free Cash Flow High	- -	- -	- -	- -	- -	11.33	19.53	11.26	-19.16	9.73	21.44	20.91	18.64	18.8	24.05
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	7.67	13.25	7.5	-11.31	5.08	14.69	11.57	13.53	9.38	12.31
EV/Sales Average	- -	- -	- -	- -	- -	2.57	2.95	2.49	2.43	2.68	4.37	4.14	3.71	3.64	3.99
EV/Sales High	- -	- -	- -	- -	- -	3.26	3.85	3.37	3.41	3.86	5.12	5.75	4.68	5.5	6.21
EV/Sales Low	- -	- -	- -	- -	- -	1.99	2.49	2.01	1.83	1.68	3.3	2.71	3.13	2.22	2.73
EV/EBITDA Average	- -	- -	- -	- -	- -	3.75	6.02	4.82	- -	6.17	12.16	7.77	6.98	7.22	8.05
EV/EBITDA High	- -	- -	- -	- -	- -	4.76	7.85	6.52	- -	8.9	14.25	10.8	8.8	10.91	12.52
EV/EBITDA Low	- -	- -	- -	- -	- -	2.92	5.07	3.88	- -	3.88	9.17	5.09	5.88	4.41	5.51
EV/EBIT Average	- -	- -	- -	- -	- -	3.87	6.25	5.04	- -	6.69	13.25	8.17	7.3	7.6	8.52
EV/EBIT High	- -	- -	- -	- -	- -	4.9	8.14	6.81	- -	9.65	15.52	11.36	9.19	11.49	13.24
EV/EBIT Low	- -	- -	- -	- -	- -	3	5.27	4.05	- -	4.21	10	5.36	6.15	4.65	5.82
Last Price	- -	- -	- -	- -	- -	144.08	149.68	105.81	89.06	151.33	215.25	275.73	218.84	354.99	503.06
High Price	- -	- -	- -	- -	- -	145.4	168.7	152.06	126.96	151.94	216.38	286.08	280.38	418.95	519.7
Enterprise Value Average	- -	- -	- -	- -	- -	4,104	5,092	4,058	3,518	3,968	7,367	8,007	8,646	10,466	12,709
Enterprise Value High	- -	- -	- -	- -	- -	5,207	6,636	5,481	4,936	5,728	8,630	11,130	10,895	15,815	19,761
Enterprise Value Low	- -	- -	- -	- -	- -	3,189	4,291	3,264	2,653	2,498	5,558	5,247	7,282	6,398	8,690

Shares Outstanding	54	50	50	47	46	43	43	44	44	45	45	46	47	45	44
Diluted Weighted Avg Shares	59	53	53	54	51	47	45	44	44	45	47	49	50	49	48
Basic Weighted Avg Shares	57	52	50	48	46	44	44	44	44	44	45	46	47	45	44
Revenue per Share	13	17.59	22.31	26.75	31.87	36.5	39.21	37.42	33.08	33.56	37.54	42.56	49.73	63.66	71.84
EBITDA per Share	5.92	8.62	6.47	11.85	15.91	24.96	19.23	19.34	-3.24	14.56	13.49	22.66	26.46	32.07	35.62
Operating Income per Share	5.56	8.09	5.84	11.18	15.2	24.24	23.29	18.51	-4.28	13.43	12.38	21.53	25.32	32.04	34.25
Basic EPS, GAAP	3.81	5.84	3.49	7.06	14.17	16.29	9.5	13.54	-2.39	11.65	10.6	15.98	21.04	26.44	30.13
Basic EPS from Cont Ops	3.8	5.84	3.49	7.06	14.17	16.29	9.5	13.54	-2.39	11.65	10.6	15.98	21.04	26.44	30.13
Diluted EPS, GAAP	3.67	5.71	3.28	6.28	12.72	15.25	9.31	13.39	-2.39	11.54	10.06	15	19.81	24.64	27.86
Diluted EPS from Cont Ops	3.66	5.71	3.28	6.28	12.72	15.25	9.31	13.39	-2.39	11.54	10.06	15	19.81	24.64	27.86
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	4.38	6.21	8.49	7.38	8.32	14.69	10.78	17.89	-4.72	17.1	13.32	17.64	20.9	29.36	35.24
Free Cash Flow per Basic Share	3.75	4.06	7.86	6.39	7.24	13.71	8.82	13.66	-6.63	15.76	10.63	14.59	15.97	23.91	23.37
Cash & Equivalents per Share	7.53	9.55	13.77	14.76	20.84	24.46	21.45	32.48	33.86	41.23	42.8	61.67	63.65	72.87	66.91
Book Value per Share	17.69	21.61	24.99	26.37	34.72	43.09	48.61	63.98	63.36	76.28	87.77	104.2	127.23	143.74	162.6
Tangible Book Value per Share	17.28	21.28	24.71	25.75	34.09	42.3	47.55	60.06	59.75	72.73	86.78	103.24	124.8	141.24	159.93

United Therapeutics Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)